# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Piper Sandler analyst David Westenberg maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price targ...
Morgan Stanley analyst Tejas Savant downgrades Akoya Biosciences (NASDAQ:AKYA) from Overweight to Equal-Weight and lowers th...
BTIG analyst Mark Massaro downgrades Akoya Biosciences (NASDAQ:AKYA) from Buy to Neutral.
Craig-Hallum analyst Bill Bonello maintains Akoya Biosciences (NASDAQ:AKYA) with a Buy and lowers the price target from $7.5...
JP Morgan analyst Rachel Vatnsdal downgrades Akoya Biosciences (NASDAQ:AKYA) from Overweight to Neutral.
Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.27) per share which met the analyst consensus estimate. The c...